Abstract
This editorial discusses the findings of Elbarky et al on the role of selenoprotein P1 (SEPP1) in pediatric obesity and insulin resistance. Their study uncovered significantly lower SEPP1 Levels in children who were obese compared with healthy peers, demonstrating a negative correlation between SEPP1 levels and measures of adiposity and insulin resistance. These findings suggest that SEPP1 is a biomarker useful in the early identification of insulin resistance in pediatric populations. This editorial emphasizes the clinical implications of the study and calls for further research to validate and explore the role of SEPP1 in metabolic health.
| Original language | English |
|---|---|
| Article number | 99652 |
| Journal | World Journal of Clinical Pediatrics |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarkers
- Insulin resistance
- Metabolic health
- Pediatric obesity
- Selenoprotein P1
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Fingerprint
Dive into the research topics of 'Selenoprotein P1 as a biomarker of insulin resistance in pediatric obesity: Insights and implications'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS